secwatch.observer — SEC 8-K summary
======================================

Issuer:     Trulieve Cannabis Corp. (TCNNF)
CIK:        0001754195
Form:       8-K
Filed at:   2022-11-09T23:59:59+00:00
Accession:  0001193125-22-281243
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Trulieve Q3 revenue $301M (+34% YoY); net loss $115M with $93M impairments; adj. EBITDA $99M
--------------------------------------------------------------------------------

- Revenue $301M (+34% YoY); 94% retail; GAAP gross margin 56%, gross profit $168M.
- Net loss $115M includes $93M asset impairments from exiting CA dispensaries, redundant FL cultivation, and NV wholesale.
- Adjusted net income $4M (excl. $26M transaction/integration charges & $93M impairments); adj. EBITDA $99M (33% margin).
- Cash $114M; capex $38M; expects significant decline in supply chain investments in 2023.
- Opened 11 new dispensaries in AZ, FL, WV; first Trulieve-branded store in Phoenix; began cultivation in Georgia.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1754195/000119312522281243/0001193125-22-281243-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1754195/000119312522281243/d411970d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-281243

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer